Biomedical Research and Training Institute, Harare, Zimbabwe.
PLoS One. 2013;8(2):e55872. doi: 10.1371/journal.pone.0055872. Epub 2013 Feb 11.
Limited data exist on use of the microscopic-observation drug-susceptibility (MODS) assay among persons suspected of MDR-TB living in high HIV-prevalence settings.
We retrospectively reviewed available clinical and drug susceptibility data for drug-resistant TB suspects referred for culture and drug-susceptibility testing between April 1, 2011 and March 1, 2012. The diagnostic accuracy of MODS was estimated against a reference standard including Löwenstein-Jensen (LJ) media and manual liquid (BACTEC MGIT) culture. The accuracy of MODS drug-susceptibility testing (DST) was assessed against a reference standard absolute concentration method.
One hundred thirty-eight sputum samples were collected from 99 drug-resistant TB suspects; in addition, six previously cultured MDR isolates were included for assessment of DST accuracy. Among persons with known HIV infection status, 39/59 (66%) were HIV-infected. Eighty-six percent of patients had a history of prior TB treatment, and 80% of individuals were on antituberculous treatment at the time of sample collection. M. tuberculosis was identified by reference standard culture among 34/98 (35%) MDR-TB suspects. Overall MODS sensitivity for M. tuberculosis detection was 85% (95% CI, 69-95%) and specificity was 93% (95% CI, 84-98%); diagnostic accuracy did not significantly differ by HIV infection status. Median time to positivity was significantly shorter for MODS (7 days; IQR 7-15 days) than MGIT (12 days; IQR 6-16 days) or LJ (28 days; IQR 21-35 days; p<0.001). Of 33 specimens with concurrent DST results, sensitivity of the MODS assay for detection of resistance to isoniazid, rifampin, and MDR-TB was 88% (95% CI, 68-97%), 96% (95% CI, 79-100%), and 91% (95% CI, 72-99%), respectively; specificity was 89% (95% CI, 52-100%), 89% (95% CI, 52-100%), and 90% (95% CI, 56-100%), respectively.
In a high HIV-prevalence setting, MODS diagnosed TB and drug-resistant TB with high sensitivity and shorter turnaround time compared with standard culture and DST methods.
在艾滋病毒高发环境中,耐多药结核病(MDR-TB)患者的显微镜观察药物敏感性(MODS)检测的应用数据有限。
我们回顾性分析了 2011 年 4 月 1 日至 2012 年 3 月 1 日期间接受培养和药敏检测的疑似耐多药结核病患者的临床和药敏数据。MODS 的诊断准确性通过包括 Löwenstein-Jensen(LJ)培养基和手动液体(BACTEC MGIT)培养的参考标准进行评估。MODS 药敏检测(DST)的准确性通过参考标准绝对浓度法进行评估。
从 99 例耐多药结核病疑似患者中采集了 138 份痰样本;此外,还纳入了 6 份先前培养的 MDR 分离株,以评估 DST 准确性。在已知 HIV 感染状况的人群中,59 例中有 39 例(66%)感染了 HIV。86%的患者有既往结核病治疗史,80%的患者在样本采集时正在接受抗结核治疗。34/98(35%)例耐多药结核病疑似患者通过参考标准培养鉴定出结核分枝杆菌。MODS 检测结核分枝杆菌的总敏感性为 85%(95%CI,69-95%),特异性为 93%(95%CI,84-98%);HIV 感染状况对诊断准确性无显著影响。MODS 的阳性时间中位数明显短于 MGIT(7 天;IQR 7-15 天)或 LJ(28 天;IQR 21-35 天;p<0.001)。在 33 份具有同步药敏结果的标本中,MODS 检测对异烟肼、利福平耐药和 MDR-TB 的敏感性分别为 88%(95%CI,68-97%)、96%(95%CI,79-100%)和 91%(95%CI,72-99%);特异性分别为 89%(95%CI,52-100%)、89%(95%CI,52-100%)和 90%(95%CI,56-100%)。
在艾滋病毒高发环境中,与标准培养和 DST 方法相比,MODS 检测结核病和耐药结核病的诊断具有较高的敏感性和较短的周转时间。